Our Team

Olof Dahlqvist Leinhard is AMRA’s Chief Executive Officer and one of the co-founders of AMRA. Olof has a background and PhD within MR physics and has, since founding AMRA in 2010, led the company’s clinical research in the role as Chief Scientific Officer. He also holds a position as a university lecturer at the Department of Health, Medicine and Caring Sciences at Linköping University and has authored over 100 peer-reviewed journal articles in the scientific fields of MR physics, clinical imaging, metabolic research, musculoskeletal research, and neuromuscular diseases.

Klas Themner is AMRA’s Chief Financial Officer and deputy CEO. Klas joined AMRA in 2017 as CFO & SVP Product Management and has since had different roles in the company. Before joining AMRA Medical he had 20+ years of experience as CFO & COO in a number of different listed medical device companies within advanced medical image processing and across all imaging modalities. Previously to Life Science, Klas spent 10 years with the Swedish defense industry. He has an engineering background and holds a PhD in Nuclear Physics from Lund University.

As AMRA’s Chief Globalization Officer, Leanna S. Kellerman is responsible for the company’s Business Development strategy and Sales operations. Leanna comes with a career history of successful Global Development and Sales Management in startup, expansion, and Fortune 500 environments. Her areas of expertise include territory development and implementation of business infrastructure, sales strategy, operations, analytics, accountability, and tactical execution that propels revenue and profit in highly competitive markets. She holds Master of Business Administration degree from Lindenwood University, St. Charles.

Jennifer Linge is AMRA’s Chief Scientific Officer, with the strategic responsibility for AMRA’s scientific development and clinical research. She joined AMRA in 2015, and spent the first 10 years on research and concept development around muscle composition and fat distribution patterns in metabolic- and wasting disorders. She has a MSc in engineering mathematics, focused on biological- and medical modelling, and a PhD in medical sciences, focused on muscle composition and sarcopenia. She is also an affiliated researcher at the Department of Health, Medicine and Caring Sciences at Linköping University.

Ola Petersson is AMRA’s Chief Technology Officer. 

Ola has over 20 years of experience in systems and software development in mixed applications and various industries. Before transitioning to Life Science, he managed the development of machine vision systems for industrial robotics applications for about 10 years. Ola holds an MSc in Computer Science & Engineering at Linköping University.

Josephine Ovemyr is AMRA’s SVP of QA/RA and is responsible for the company quality, including the quality management system, as well as national and international regulatory compliance and approvals. She has over 15 years of experience in the pharmaceutical and medical device industries, with a background spanning Quality Control, Manufacturing, Quality Assurance, and Regulatory Affairs. Josephine has previously held roles supporting both product development and commercial operations, ensuring compliance and operational excellence across global markets. She holds an MSc in Biomedical Sciences from Linköping University.

Mikaela Odlander is AMRA’s SVP for Business Strategy and joined the
company in 2025. She has a decade of experience in international
commercial and strategic roles within Pharma and HealthTech spanning
across start-ups to Fortune 500 companies. Mikaela holds an MSc in
Technology Management from UCL in the UK.

André Melin is AMRA’s SVP of Science & Imaging, responsible for the scientific and technical aspects of imaging, biomarker quantification and clinical science and applications. Through this role, he ensures that AMRA maintains a strong position as a technology- and science-based company. He leads a team with imaging and clinical science experts that makes sure that AMRA’s MRI protocols, biomarkers and clinical applications are validated and reliable. The team also has a strong focus on developing the clinical usage and clinical translations of AMRA’s technologies, as well as maximizing the clinical value for the customer in every delivery.

André is an MRI physicist with over 15 years of experience in MRI method development, research and applications. He holds a PhD in Medical Radiation Physics from Lund University in Sweden, where he focused on methodological improvements in quantitative brain MRI. The last five years he has held different positions at AMRA including Imaging Scientist, Director of Imaging, and latest SVP Science & Imaging.

Sofia leads the Operational team at AMRA, including the Clinical Project Management, Production and Customer Support teams.
With over 15 years of experience in the pharmaceutical industry, she has held several operational roles in clinical trials, ranging from investigational drug production to hands-on trial management at investigational sites.
Sofia holds an MSc in Biomedical Sciences from Lund University.

As AMRA’s Controller, Caroline Bergengren is responsible for the accounting processes, maintaining financial compliance and providing reports to ensure well-informed decision-making throughout the business. She has financial experience from several industries ranging from manufacturing to consultancy and holds a Master of Science in Business and Economics from Linköping University.